RNA
#3603
Atrium Therapeutics, Inc. - Common Stock
12.2 2 USD
-0.02%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-1.93%
Monthly Change
-1.45%
6 month change
-83.15%
Year Change
-82.62%
Previous Close
12.4 6
Open
12.2 2
Low
12.2 2
High
12.2 2
Volume
28
Financials
- Market Capitalization 209.03 M
- Employee 391
- Founded 2025
- CEO Troy Wilson
- Website www.aviditybiosciences.com
- Headquarter Delaware, United States
- FIGI BBG01Z0T3959
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3584 |  CGEN Compugen Ltd. - Ordinary Shares | 2.30 USD | -3.77% | -1.71% | +13.30% | +42.86% | 217.47 M USD | ||
| 3589 |  NBP NovaBridge Biosciences - American Depositary Shares | 1.86 USD | -2.11% | -7.46% | +25.68% | -58.76% | 214.61 M USD | ||
| 3607 |  CLLS Cellectis S.A. - American Depositary Shares | 2.89 USD | -3.34% | -10.80% | -6.77% | +25.65% | 207.36 M USD | ||
| 3613 |  SLGL Sol-Gel Technologies Ltd. - Ordinary Shares | 73.91 USD | -0.05% | +0.03% | +1.25% | +833.21% | 205.92 M USD |
Frequently asked questions about Atrium Therapeutics, Inc. - Common Stock
What is the Atrium Therapeutics, Inc. - Common Stock stock price today?
The current price of Atrium Therapeutics, Inc. - Common Stock (RNA) is 12.22. Over the past 24 hours, the stock has changed by -1.93%. Follow the RNA chart for real-time price dynamics.
What is the stock ticker of Atrium Therapeutics, Inc. - Common Stock?
Atrium Therapeutics, Inc. - Common Stock trades under the ticker RNA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Atrium Therapeutics, Inc. - Common Stock stock going up?
RNA has changed by -7.00% over the last week, -1.45% over the last month, and -82.62% over the last year. Review the chart to see whether the current move is part of a broader trend.
How many employees does Atrium Therapeutics, Inc. - Common Stock have?
As of the latest available data, Atrium Therapeutics, Inc. - Common Stock has 391 employees. Workforce size can provide additional context about the company's scale and operations.
What is Atrium Therapeutics, Inc. - Common Stock EBITDA?
Atrium Therapeutics, Inc. - Common Stock EBITDA is -17.13 M, and its EBITDA margin is -87.24%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Atrium Therapeutics, Inc. - Common Stock stock?
You can buy Atrium Therapeutics, Inc. - Common Stock (RNA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Atrium Therapeutics, Inc. - Common Stock stock?
Investing in Atrium Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the RNA chart and related analysis on metatrader.com as part of your research.